The evolving role of tor inhibitors for individualizing posttransplant immunosuppression.
Lorber
M I
MI
Department of Surgery, Organ Transplantation & Immunology Section, Yale University School of Medicine, New Haven, CT 06520, USA.
Basadonna
G P
GP
Friedman
A L
AL
Lorber
K M
KM
Bia
M J
MJ
Formica
R
R
Smith
J D
JD
D065095:Calcineurin Inhibitors; D000068338:Everolimus; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011499:Protein Processing, Post-Translational / Q000276:immunology*; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use; D014181:Transplantation Immunology
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus